跳至主要内容
临床试验/NCT05245383
NCT05245383Unknown不适用

Skin Irritation Test of Ten Products

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年12月17日最近更新:
适应症

试验速览

阶段
不适用
入组人数
30
试验地点
1
主要终点
Safety/Adverse Event Outcome Measure

研究概览

简要总结

Evaluation of cutaneous tolerance of ten products by primary irritant patch test

详细描述

The purpose of this clinical study was the evaluation of skin irritation potential of ten products after a single application under occlusive patch on human skin.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 20 to 70 years old, healthy male and female (sex ratio 1:1)
  • No acute or chronic diseases including skin diseases.
  • No current medications.

排除标准

  • Pregnancy or breast feeding.
  • Abnormal blood test result/results (evaluation criteria: WBC, AST, ALT, and Creatinine)
  • Back skin with moles, acne, tattoo, scars, red spots, burns, etc.
  • Current dermatology medication which might affect skin condition evaluation.
  • Current irritated reaction on test site.
  • Participating in other clinical trial(s) within 7 days.

结局指标

主要结局

Safety/Adverse Event Outcome Measure

时间窗: Up to 48 hours

Number of participants with Serous and Non-Serous Adverse Event

Total Number of Positive Responses Across All Participants

时间窗: Reading results at 30 minutes, 24 hours and 48 hours after the removal of the test products.

Change from baseline of test products by using ICDRG (International Contact Dermatitis Research Group) grading

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Skin Irritation Test of Ten Products | 临床试验